Tags

Type your tag names separated by a space and hit enter

Designing drug-usage evaluation to meet Joint Commission requirements.
Pharm Pract Manag Q. 1996 Jul; 16(2):26-35.PP

Abstract

Strategies for influencing prescribing practices utilizing the drug-usage evaluation (DUE) process are described. Our DUE program has evolved into a collaborative program that provides significant pharmacy involvement while maintaining medical staff responsibility, as outlined by the Joint Commission on Accreditation of Healthcare Organizations (Joint Commission). A multidisciplinary approach is utilized to identify prescribing problems, develop prescribing criteria, and provide educational initiatives. Pharmacists provide drug therapy monitoring, engage in clinical interventions, and document the outcomes of these interventions. DUE pharmacists report results of these initiatives to the medical staff and quality assessment program. Physician performance compliance is incorporated into the credentialing process. Corrective measures are determined by the Pharmacy and Therapeutics Subcommittee, with subsequent actions carried out by peer physicians. The net result is a positive influence on prescribing practices that improves the appropriate and effective use of drugs, while meeting Joint Commission standards.

Authors+Show Affiliations

The University of Iowa Hospitals and Clinics, Iowa City 52242, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10161608

Citation

Peroutka, J A.. "Designing Drug-usage Evaluation to Meet Joint Commission Requirements." Pharmacy Practice Management Quarterly, vol. 16, no. 2, 1996, pp. 26-35.
Peroutka JA. Designing drug-usage evaluation to meet Joint Commission requirements. Pharm Pract Manag Q. 1996;16(2):26-35.
Peroutka, J. A. (1996). Designing drug-usage evaluation to meet Joint Commission requirements. Pharmacy Practice Management Quarterly, 16(2), 26-35.
Peroutka JA. Designing Drug-usage Evaluation to Meet Joint Commission Requirements. Pharm Pract Manag Q. 1996;16(2):26-35. PubMed PMID: 10161608.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Designing drug-usage evaluation to meet Joint Commission requirements. A1 - Peroutka,J A, PY - 1996/6/6/pubmed PY - 1996/6/6/medline PY - 1996/6/6/entrez SP - 26 EP - 35 JF - Pharmacy practice management quarterly JO - Pharm Pract Manag Q VL - 16 IS - 2 N2 - Strategies for influencing prescribing practices utilizing the drug-usage evaluation (DUE) process are described. Our DUE program has evolved into a collaborative program that provides significant pharmacy involvement while maintaining medical staff responsibility, as outlined by the Joint Commission on Accreditation of Healthcare Organizations (Joint Commission). A multidisciplinary approach is utilized to identify prescribing problems, develop prescribing criteria, and provide educational initiatives. Pharmacists provide drug therapy monitoring, engage in clinical interventions, and document the outcomes of these interventions. DUE pharmacists report results of these initiatives to the medical staff and quality assessment program. Physician performance compliance is incorporated into the credentialing process. Corrective measures are determined by the Pharmacy and Therapeutics Subcommittee, with subsequent actions carried out by peer physicians. The net result is a positive influence on prescribing practices that improves the appropriate and effective use of drugs, while meeting Joint Commission standards. SN - 1080-5737 UR - https://www.unboundmedicine.com/medline/citation/10161608/Designing_drug_usage_evaluation_to_meet_Joint_Commission_requirements_ DB - PRIME DP - Unbound Medicine ER -